NERVGEN PHARMA CORP. Proceeds From Exercise Of Warrants
NERVGEN PHARMA CORP. (NGEN) reported Proceeds From Exercise Of Warrants of CAD 3.39 million for the 12-month period ending 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2026-03-31
| Period end | Proceeds From Exercise Of Warrants 12 month |
|---|---|
| 2025-12-31 | 3.39M CAD 40-F · filed 2026-03-31 |
| 2024-12-31 | 139.25K CAD 40-F · filed 2026-03-31 |